PDGFRB and glioblastoma: In contrast, PDGFRB showed a decreased expression in the pseudo-palisading regions (43), indicating the critical role of PDGFRB in angiogenesis and GBM invasion, two critical phenotypes that are the subject of therapeutic intervention.